BPC-157 + TB-500 for Dogs
The "wolverine stack" is the most searched pet-peptide combo. Here is what the animal data supports, what has never been tested in dogs, and how to think about it honestly.
What's in the Stack
A synthetic pentadecapeptide. In rat models it promoted tendon-cell outgrowth, survival and migration (PMID 21030672) and improved ligament healing (PMID 20225319). Mechanism data is rodent and in-vitro, not canine.
A synthetic fragment of thymosin beta-4, an actin-sequestering protein that supports cell migration and wound repair (PMID 16099219) and dampens inflammation (PMID 30063848). Reviews only; no canine trial.
A 2026 rat Achilles-transection study (PMID 42542926) tested BPC-157 (10 µg/kg/day) and TB-500 (60 µg/kg/day) alone and combined; TB-500 and the combination significantly improved tendon architecture (Movin scores). Rats, not dogs.
What the Data Shows
Daily Dosing Schedule
Key Takeaways
- BPC-157 and TB-500 are synthetic peptides with soft-tissue-repair activity in rodent and in-vitro models.
- A 2026 rat Achilles study found the combination and TB-500 alone significantly improved tendon architecture (PMID 42542926).
- BPC-157 has been characterized pharmacokinetically in beagle dogs: ~45-51% intramuscular bioavailability, elimination half-life under 30 minutes (PMID 36588717).
- The peptides clear the bloodstream quickly, which is why owner protocols use daily dosing.
- No controlled efficacy trial of BPC-157 or TB-500 in dogs has been published (PubMed searches, 2026: 0 results).
- There is no established or veterinary-endorsed dose for either peptide in dogs.
- The rat tendon doses (µg/kg) are not a canine protocol and should not be scaled to a dog.
- Long-term safety of these peptides in dogs is unstudied.
Frequently Asked Questions
Is there any real study of BPC-157 and TB-500 in dogs?
The only published canine data is a pharmacokinetic study in beagle dogs (PMID 36588717) that measured how BPC-157 is absorbed and cleared. It was not an efficacy or arthritis trial. No controlled study has tested whether either peptide helps a dog heal.
What doses were used in the rat tendon study?
BPC-157 at 10 µg/kg/day and TB-500 at 60 µg/kg/day, given intraperitoneally for four weeks (PMID 42542926). These are rat-model doses in a lab setting, not a recommendation for dogs.
Why do so many sites list confident dog doses?
Because they are copying each other, not a study. No peer-reviewed canine dosing protocol exists. Any specific dog dose you see online is someone’s guess or extrapolation from human or rodent numbers.
What should I actually do?
Talk to a veterinarian, especially one open to discussing regenerative options, and treat online protocols as anecdotes rather than instructions.
🧪 Buy BPC-157 + TB-500 Blend — Research Grade
Swiss Chems publishes third-party HPLC COAs for selected products — vendor-published, a claim to verify. Deep-linked to the BPC-157 + TB-500 Blend product page.
Buy BPC-157 + TB-500 Blend at Swiss Chems →Affiliate links — support HighPeptides at no extra cost.
🛒 Recommended Products
Support supplements and gear relevant to this protocol.
Affiliate links — support HighPeptides at no extra cost.
📚 Related HighPeptides Research
Peer-Reviewed References
47-page guide: protocols, dosing, sourcing — everything in one place.
Get the guide — $19 (normally $29) → The Peptide Buyer’s Playbook — $19 All ebooks & guides →Educational purposes only. Not medical advice.
Not veterinary advice; consult a veterinarian.
Peptides referenced here are sold for laboratory research use only. Nothing on this page endorses administering them to an animal.
Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars — metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.